Hyperion Capital Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-71,476
Closed -$5.65M – 69
2026
Q2
$5.65M Sell
71,476
-69,373
-49% -$5.9M 2.55% 12
2026
Q1
$12.1M Sell
140,849
-6,008
-4% -$539K 5.84% 5
2025
Q4
$12.8M Buy
+146,857
New +$11.1M 6.28% 6

Other funds holding GMED

Hyperion Capital Advisors's GMED Position: Q3 2026 in Review

Hyperion Capital Advisors sold out of Globus Medical (GMED) in Q3 2026, closing a stake of 71,476 shares — an estimated $5.65M sold.

Hyperion Capital Advisors first reported a position in GMED in Q4 2025 and held it in 3 quarters. The position peaked at $12.8M in Q4 2025. 611 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Hyperion Capital Advisors reported no remaining Globus Medical position as of Q3 2026 after selling out during the quarter.
  • Hyperion Capital Advisors sold 71,476 Globus Medical shares in Q3 2026, an estimated $5.65M.
  • Hyperion Capital Advisors first reported a position in Globus Medical in Q4 2025 and held it in 3 quarters.
  • Hyperion Capital Advisors's Globus Medical position peaked at $12.8M in Q4 2025.
  • 611 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Hyperion Capital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.